NORMUNITY
Live / Applied — Fourth extension granted (statement of use) (as of 28 Aug 2025)
What this means for you
Not registered yet, but its 05 Oct 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97619994
- Mark type
- Design + words
- Filed
- 05 Oct 2022
- Published for opposition
- 11 Jul 2023
- Attorney of record
- Glenn M. Cunningham
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating human diseases, namely, for treating oncological, autoimmune, and immune-oncological diseases and other related diseases in the fields of oncology, autoimmune, and immune-oncology
- Class 042 — Scientific and technological services: Medical and scientific research in the field of human diseases; pharmaceutical research and development; pharmaceutical research and development, namely, research and development of pharmaceutical technology in the field of therapeutic antibodies and biopharmaceuticals
Owner
- Normunity, Inc., New Haven, CT, US
- Normunity, Inc., Westport, CT, US
Prosecution history
- 04 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Aug 2025 — SOU EXTENSION 4 GRANTED
- 28 Aug 2025 — SOU EXTENSION 4 FILED
- 28 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2025 — SOU EXTENSION 3 GRANTED
- 26 Feb 2025 — SOU EXTENSION 3 FILED
- 26 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 31 Oct 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 31 Oct 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2024 — SOU EXTENSION 2 GRANTED
- 04 Sept 2024 — SOU EXTENSION 2 FILED